Literature DB >> 6967092

In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults.

W J Koopman, R E Schrohenloher.   

Abstract

Peripheral blood mononuclear leukocytes (MNL) from 22 healthy adults were tested for their capacity to produce IgM rheumatoid factor (RF) in vitro in the presence and absence of pokeweed mitogen (PWM). In no instance was spontaneous elaboration of IgM RF observed. However, stimulation of MNL with PWM resulted in the induction of IgM RF synthesis in 10 out of 22 individuals. The IgM RF in these culture fluids constituted only a small fraction of the total IgM (mean +/- 1 S.D. = 1.01 +/- 1.08%). The lack of correlation of IgM RF with total IgM in these culture fluids argued against nonspecific absorption of non-RF IgM on the IgG substrate utilized in the assay. Furthermore, fraction of supernatants containing IgM RF on Sephadex G-200 indicated the material to co-elute with polymeric IgM and to preferentially bind to Fc coated tubes as opposed to Fab or BSA-coated assay tubes. IgM RF production induced by PWM was dependent upon de novo protein synthesis and exhibited T cell dependence. The data indicate that B cells capable of synthesizing RF commonly occur in normal individuals but are not ordinarily activated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Bacterial peptidoglycan induces in vitro rheumatoid factor production by lymphocytes of healthy subjects.

Authors:  R J Levy; M Haidar; H Park; L Tar; A I Levinson
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

2.  Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin.

Authors:  H H Birdsall; R D Rossen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.

Authors:  W J Van Esch; C C Reparon-Schuijt; E W Levarht; C Van Kooten; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families.

Authors:  G S Alarcón; B O Barger; R C Go; R T Acton; R E Schrohenloher; W J Koopman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

5.  Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis.

Authors:  V Patel; G S Panayi
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  Analysis of in vitro polyclonal B cell differentiation responses to bacterial peptidoglycan and pokeweed mitogen in rheumatoid arthritis.

Authors:  I Pardo; C Carafa; R Dziarski; A I Levinson
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

7.  Production of antibodies specific for Fc, Fab', and streptokinase-streptodornase in vitro by peripheral blood cells from patients with rheumatoid arthritis and normal donors. Identification of immune complexes in culture supernatants containing hidden antibodies reactive with Fab' fragments of immunoglobulin G.

Authors:  H H Birdsall; R D Rossen
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.

Authors:  N Olsen; M Ziff; H E Jasin
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  Selective induction of rheumatoid factors by superantigens and human helper T cells.

Authors:  X W He; J Goronzy; C Weyand
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  Persistence of a rheumatoid factor (RF)-producing B cell clone with a somatically mutated Ig kappa chain in a patient with rheumatoid arthritis.

Authors:  A Schrauder; A Gause; W Jung; R Mierau; M Pfreundschuh
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.